Domark International (DOMK) 10-K 14 Sep 15 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - May. 31, 2015 - USD ($)	Total
Document And Entity Information
Entity Registrant Name	Domark International Inc.
Entity Central Index Key	1,365,160
Document Type	10-K
Document Period End Date	May 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--05-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float	$ 3,750,000
Entity Common Stock, Shares Outstanding	8,805,932,169
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	May. 31, 2015	May. 31, 2014
CURRENT ASSETS
Cash and cash equivalents		$ 460
Loan receivable from consultant	$ 36,203	36,203
Prepaid expenses	4,500	4,500
TOTAL CURRENT ASSETS	40,703	41,163
INVESTMENTS	1,144,166	1,144,166
OTHER ASSETS
Patents, net of accumulated amortization of $13,605 and $3,605, respectively	56,897	66,897
Licenses, net of accumulated amortization of $268,338 and $60,898 respectively	41,662	249,102
TOTAL OTHER ASSETS	98,559	315,999
TOTAL ASSETS	1,283,428	$ 1,501,328
CURRENT LIABILITIES
Accounts payable to Bank	115
Note payable to bank	198,000	$ 180,000
Accounts payable and accrued expenses	855,665	56,940
Amounts due under Licensing Agreement with Wazzamba SA	224,924	224,925
Loans payable to consultants and stockholders	189,928	188,972
Convertible notes payable (net of unamortized discounts of $58,938 and $674,886 respectively)	580,956	67,414
Derivative liability for convertible notes payable	2,564,280	1,748,982
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	4,613,868	2,467,233
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares as of May 31, 2015 and May 31, 2014	$ 50	$ 50
Convertible preferred stock series B, $0.0001 par value, Authorized: 10,000,000
Common stock, $0.001 par value, authorized 14,000,000,000 shares: 8,805,932,169 and 801,626,781 shares issued, and 8,681,112,367 and 676,806,979 shares outstanding as of May 31, 2015 and May 31, 2014	$ 8,805,932	$ 801,627
Less: Treasury stock (124,819,802 shares) as of May 31, 2015 and May 31, 2014	(124,820)	(124,820)
Common stock payable	858,000	858,000
Additional paid-in capital	36,219,642	43,529,923
Other comprehensive income (loss)	(126,453)	(88,551)
Accumulated deficit	(48,962,791)	(45,942,134)
TOTAL STOCKHOLDERS' DEFICIT	(3,330,440)	(965,905)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,283,428	$ 1,501,328

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	May. 31, 2015	May. 31, 2014
OTHER ASSETS
Patents, net of accumulated amortization	$ 13,605	$ 3,605
License, net of accumulated amortization	268,338	60,898
CURRENT LIABILITIES
Convertible notes payable net of unamortized discounts	$ 58,938	$ 674,886
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock series A, par value	$ 0.001	$ 0.001
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Convertible preferred stock series B, par value	0.0001	0.0001
Convertible preferred stock series B, shares authorized	10,000,000	10,000,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	14,000,000,000	14,000,000,000
Common Stock, shares issued	8,805,932,169	801,626,781
Common Stock, shares outstanding	8,681,112,367	676,806,979
Treasury Stock, Shares	124,819,802	124,819,802

Consolidated Statements Of Oper

Consolidated Statements Of Operations (Unaudited) - USD ($)	12 Months Ended
	May. 31, 2015	May. 31, 2014
Consolidated Statements Of Operations
Sales
Cost of sales
Gross profit
Operating expenses:
General and administrative	$ 1,102,920	$ 1,027,248
Stock-based compensation - consultants	$ 79,623	666,755
Stock-based compensation - Salaries and wages		156,600
Depreciation and amortization expense	$ 217,440	62,685
Total operating expenses	1,399,983	1,913,288
Loss from operations	$ (1,399,983)	$ (1,913,288)
Other income (expense):
Other income
Revaluation of derivative liability for convertible notes	$ (815,302)	$ (1,213,154)
Interest expense	(805,370)	(511,876)
Total other income (expense)	(1,620,672)	(1,725,030)
Net Loss	(3,020,655)	(3,638,318)
Statement of Comprehensive Income: Net Loss	(3,020,655)	(3,638,318)
Other Comprehensive Loss
Foreign Currency Adjustment	(37,902)	(88,551)
Total Other Comprehensive Loss	(37,902)	(88,551)
Total Comprehensive loss	$ (3,058,557)	$ (3,726,869)
Net loss per common share, basic and diluted	$ 0	$ (0.01)
Weighted average common shares outstanding	4,709,452,486	298,705,632

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	May. 31, 2015	May. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (3,020,655)	$ (3,726,869)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	217,440	$ 62,685
Common stock issued for compensation - consultants	$ 79,623
Common stock issued as compensation		$ 823,355
Non cash interest expense	$ 805,370	451,988
Loss (gain) on derivative valuation Currency loss	$ 815,302	1,213,154
Changes in Operating assets and liabilities:
Prepaid expenses		13,323
Accounts payable and accrued expenses	$ 798,725	$ (152,062)
Accounts payable -related party	956
Net cash used in operating activities	$ (303,239)	$ (1,323,233)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments		(159,550)
Cash paid for loan receivable from consultant		(36,203)
Net cash used in investing activities		(195,753)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	$ 208,863	1,162,500
Payments made on amounts due under License Agreement with Wazzamba S. A.		(75,075)
Proceeds from loans payable to consultants and stockholders	$ 131,703	262,542
Payments made on loans payables to consultants & stockholders		(10,541)
Proceeds received from notes payable		180,000
Net cash provided by financing activities	$ 340,566	$ 1,519,426
Other comprehensive income ( loss ) effect of exchange rate changes on cash	(37,902)
Net increase (decrease) in cash and cash equivalents	(575)	$ 440
CASH BALANCE - BEGINNING OF PERIOD	460	20
CASH BALANCE (BANK OVERDRAFT) - END OF PERIOD	(115)	460
Cash paid for interest	$ 20,424	9,700
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Licensing Agreement with Wazzamba SA in exchange for amounts due under Licensing agreement with Wazzamba SA		300,000
Shares issued for settlement of loans payable to consultants and stockholders	$ 65,102	159,991
Shares issued for settlement of convertible notes payable	$ 487,998	731,329
Shares issued for patent acquisition		35,500
Shares issued for equity interests in Imagic Ltd.		796,700
Shares issued for equity interest in Barefoot Science Products & Services, Inc.		45,000
Convertible notes payable issued for equity interests in Imagic Ltd.		$ 150,000

Consolidated Statement Of Stock

Consolidated Statement Of Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Common Stock Payable [Member]	Accumulated During Dev. Stage	Treasury Stock	OCI	Total
Beginning Balance, Shares at May. 31, 2013	50,000	179,435,100				(124,819,802)
Beginning Balance, Amount at May. 31, 2013	$ 50	$ 179,435	$ 40,816,440	$ 858,000	$ (42,303,816)	$ (124,820)		$ (574,711)
Net loss								(3,638,318)
Ending Balance, Amount at May. 31, 2014								(965,905)
Beginning Balance, Shares at May. 31, 2013	50,000	179,435,100				(124,819,802)
Beginning Balance, Amount at May. 31, 2013	$ 50	$ 179,435	40,816,440	858,000	(42,303,816)	$ (124,820)		(574,711)
Common Stock issued for related party loan June17,2013, Shares		2,500,000
Common Stock issued for related party loan June17,2013, Amount		$ 2,500	47,500					50,000
Common Stock issued for consulting (Meadow) 6/29/2013($.101)x, Share		2,500,000
Common Stock issued for consulting (Meadow) 6/29/2013($.101)x, Amount		$ 2,500	247,500					250,000
Common Stock issued for web development(KC) 7/5/2013($.09), Shares		250,000
Common Stock issued for web development(KC) 7/5/2013($.09), Amount		$ 250	22,250					22,500
Comon Stock issued for Investment Tech 7/9/2013($.089), Shares		75,000
Comon Stock issued for Investment Tech 7/9/2013($.089), Amount		$ 75	6,600					6,675
Common Stock issued for IR consulting(Davis) 7/17/2013($.0833), Shares		500,000
Common Stock issued for IR consulting(Davis) 7/17/2013($.0833), Amount		$ 500	41,150					41,650
Common Stock issed for related party loan(FMK) July22,2013, Shares		2,874,550
Common Stock issed for related party loan(FMK) July22,2013, Amount		$ 2,875	54,616					57,491
Common Stock issued for acquisition(Imagic) July22,2013, Shares		7,500,000
Common Stock issued for acquisition(Imagic) July22,2013, Amount		$ 7,500	690,000					697,500
Common Stock issued for consulting Bio Harmon. 8/15/2013($.071)issue($.01), Shares		500,000
Common Stock issued for consulting Bio Harmon. 8/15/2013($.071)issue($.01), Amount		$ 500	35,000					35,000
Common Stock issued for consulting(Meadow) 8/26/2013($.0655), Shares		2,000,000
Common Stock issued for consulting(Meadow) 8/26/2013($.0655), Amount		$ 2,000	131,000					133,000
Common Stock issed for loan conversion(Asher) 8/28/2013($.0359), Shares		1,114,206
Common Stock issed for loan conversion(Asher) 8/28/2013($.0359), Amount		$ 1,114	38,886					40,000
Stock issued for loan conv. Asher 9/18/13 ($25K) Bal. of loan ($14.5k), Shares		856,164
Stock issued for loan conv. Asher 9/18/13 ($25K) Bal. of loan ($14.5k), Amount		$ 856	24,144					25,000
Stock issued for consulting Caramel ( 10/9/13), Shares		1,000,000
Stock issued for consulting Caramel ( 10/9/13), Amount		$ 1,000	44,600					45,600
Stock issued for consulting (Kauffman) 10/10/13, Shares		250,000
Stock issued for consulting (Kauffman) 10/10/13, Amount		$ 250	12,250					12,500
Stock issued for loan conv Asher (11/14/13) ($14.5k) Bal. of loan ( $0), Shares		903,261
Stock issued for loan conv Asher (11/14/13) ($14.5k) Bal. of loan ( $0), Amount		$ 903	13,594					14,497
Stock issued for loan conv. Asher (11/4/13) ($$15k) Bal. of loan ($33750), Shares		1,153,846
Stock issued for loan conv. Asher (11/4/13) ($$15k) Bal. of loan ($33750), Amount		$ 1,154	13,847					15,001
Stock issued for related party loan ( Frmk) (11/7/13) $52.5k Bal. of loan ($0), Shares		3,500,000
Stock issued for related party loan ( Frmk) (11/7/13) $52.5k Bal. of loan ($0), Amount		$ 3,500	49,000					52,500
Stock issued for loan conv. Asher (11/12/13) ($15K) Bal. of loan ($18,750), Shares		1,630,435
Stock issued for loan conv. Asher (11/12/13) ($15K) Bal. of loan ($18,750), Amount		$ 1,631	13,370					15,001
Stock issued for loan conv. Iconic (11/14/13) ($13,197) Bal. of loan ($36,603), Shares		3,999,200
Stock issued for loan conv. Iconic (11/14/13) ($13,197) Bal. of loan ($36,603), Amount		$ 3,999	9,198					13,197
Stock issued for consulting (Kauffman) 11/15/13, Shares		175,000
Stock issued for consulting (Kauffman) 11/15/13, Amount		$ 175	1,575					1,750
Stock issued for loan conv. Asher (11/19/13) ($18.5K) Bal. of loan ($0), Shares		3,456,597
Stock issued for loan conv. Asher (11/19/13) ($18.5K) Bal. of loan ($0), Amount		$ 3,457	16,588					20,045
Stock issued for loan conv Iconic (11/19/13) ($22,126) Bal. of loan ($14,852), Shares		8,850,572
Stock issued for loan conv Iconic (11/19/13) ($22,126) Bal. of loan ($14,852), Amount		$ 8,850	13,276					22,126
Stock issued for investment in Imagic (12/3/13) $.0125, Shares		8,000,000
Stock issued for investment in Imagic (12/3/13) $.0125, Amount		$ 8,000	91,200					99,200
Stock issued for loan conv. Iconic (12/4/13) ($14,852) Bal. of loan ($0) $.099, Shares		7,072,457
Stock issued for loan conv. Iconic (12/4/13) ($14,852) Bal. of loan ($0) $.099, Amount		$ 7,072	7,780					14,852
Stock issued for loan conv. Icon/FrMk (12/18/13) ($11,435) Bal. of loan ($38,565)$.01, Shares		5,445,005
Stock issued for loan conv. Icon/FrMk (12/18/13) ($11,435) Bal. of loan ($38,565)$.01, Amount		$ 5,445	5,990					11,435
Stock issued for loan conv. Asher (12/26/13) ($20K) Bal. of loan ($30,050)$.02, Shares		4,166,667
Stock issued for loan conv. Asher (12/26/13) ($20K) Bal. of loan ($30,050)$.02, Amount		$ 4,167	15,833					20,000
Stock issued for loan conv. Asher (12/30/13) ($23K) Bal. of loan ($7,050)$.0125, Shares		4,791,667
Stock issued for loan conv. Asher (12/30/13) ($23K) Bal. of loan ($7,050)$.0125, Amount		$ 4,792	18,208					23,000
Stock issued for loan conv. Asher (1/6/14) ($7,050) Bal. of loan ($0)$.01, Shares		1,305,556
Stock issued for loan conv. Asher (1/6/14) ($7,050) Bal. of loan ($0)$.01, Amount		$ 1,306	5,744					7,050
Stock issued for loan conv. Iconic/FrMk (1/13/14) ($13,017) Bal. of loan ($25,548)$.009, Shares		6,198,762
Stock issued for loan conv. Iconic/FrMk (1/13/14) ($13,017) Bal. of loan ($25,548)$.009, Amount		$ 6,199	6,818					13,017
Stock issued for loan conv. Iconic/FrMk (1/23/14) ($14K) Bal of loan ($11,548) $.009, Shares		6,436,781
Stock issued for loan conv. Iconic/FrMk (1/23/14) ($14K) Bal of loan ($11,548) $.009, Amount		$ 6,437	7,563					14,000
Stock issued for loan conv. Iconic/FrMk (2/3/14) ($14,998) Bal of loan ($0) $.009, Shares		7,498,890
Stock issued for loan conv. Iconic/FrMk (2/3/14) ($14,998) Bal of loan ($0) $.009, Amount		$ 7,499	7,499					14,998
Stock issued for loan conv. JSJ (2/6/14) ($17,150) Bal of loan ($7,850) $.0082, Shares		4,900,000
Stock issued for loan conv. JSJ (2/6/14) ($17,150) Bal of loan ($7,850) $.0082, Amount		$ 4,900	12,250					17,150
Stock issued for loan conv. JMJ (2/11/14) ($10,800) Bal of loan ($11,548) $.0088, Shares		3,000,000
Stock issued for loan conv. JMJ (2/11/14) ($10,800) Bal of loan ($11,548) $.0088, Amount		$ 3,000	7,800					10,800
Stock issued for loan conv Cont. Eq. (2/11/14) ($20k) Bal of loan ($10K)$.0088, Shares		4,901,960
Stock issued for loan conv Cont. Eq. (2/11/14) ($20k) Bal of loan ($10K)$.0088, Amount		$ 4,902	15,098					20,000
Stock issued for loan conv Blk Mtn (2/13/14) ($15k) Bal of loan ($45.5)$.0088, Shares		5,000,000
Stock issued for loan conv Blk Mtn (2/13/14) ($15k) Bal of loan ($45.5)$.0088, Amount		$ 5,000	10,000					15,000
Stock issued for loan conv. JMJ (2/25/14) ($12k) Bal of loan ($27,200) $.0055, Shares		4,000,000
Stock issued for loan conv. JMJ (2/25/14) ($12k) Bal of loan ($27,200) $.0055, Amount		$ 4,000	8,000					12,000
Stock issued for loan conv. Cont. Eq. (2/26/14) ($10k) Bal of loan ($0) $.0056, Shares		3,278,688
Stock issued for loan conv. Cont. Eq. (2/26/14) ($10k) Bal of loan ($0) $.0056, Amount		$ 3,279	6,721					10,000
Stock issued for consulting (Thorsteinson) 3/3/14/$.0067, Shares		12,000,000
Stock issued for consulting (Thorsteinson) 3/3/14/$.0067, Amount		$ 12,000	68,400					80,400
Stock issued for loan conv. RdWd III (3/3/14) ($10,913) Bal of loan ($84,087), Shares		6,419,120
Stock issued for loan conv. RdWd III (3/3/14) ($10,913) Bal of loan ($84,087), Amount		$ 6,419	4,494					10,913
Stock issued for loan conv. RdWd III (3/6/14) ($10,133) Bal of loan ($73,955), Shares		6,755,135
Stock issued for loan conv. RdWd III (3/6/14) ($10,133) Bal of loan ($73,955), Amount		$ 6,755	3,378					10,133
Stock issued for loan conv. JSJ (3/6/14) ($9,178) Bal of loan ($0), Shares		3,990,435
Stock issued for loan conv. JSJ (3/6/14) ($9,178) Bal of loan ($0), Amount		$ 3,990	5,188					9,178
Stock issued for loan conv. RdWd III (3/6/14) ($10,663) Bal of loan ($63,292), Shares		7,108,733
Stock issued for loan conv. RdWd III (3/6/14) ($10,663) Bal of loan ($63,292), Amount		$ 7,109	3,554					10,663
Stock issued for consulting (Pre. Vnt. Partns) 3/17/14 $.0058, Shares		5,668,934
Stock issued for consulting (Pre. Vnt. Partns) 3/17/14 $.0058, Amount		$ 5,669	27,211					32,880
Stock issued for officers (3/17/14) AR ( 15m) TC ( 10m) Brent S. ( 2m ) $.0058, Shares		27,000,000
Stock issued for officers (3/17/14) AR ( 15m) TC ( 10m) Brent S. ( 2m ) $.0058, Amount		$ 27,000	129,600					156,600
Stock issued for loan conv. Asher (3/18/14) ($15,000) Bal. of loan ($35,050), Shares		6,818,182
Stock issued for loan conv. Asher (3/18/14) ($15,000) Bal. of loan ($35,050), Amount		$ 6,818	8,182					15,000
Stock issued for loan conv. RdWd III (3/18/14) ($12,968) Bal of loan ($50,323), Shares		10,053,100
Stock issued for loan conv. RdWd III (3/18/14) ($12,968) Bal of loan ($50,323), Amount		$ 10,053	2,915					12,968
Stock issued for consulting (Bill Sharpe) 3/19/14 $.0049, Shares		2,000,000
Stock issued for consulting (Bill Sharpe) 3/19/14 $.0049, Amount		$ 2,000	7,800					9,800
Stock issued for loan conv. Asher (3/20/14) ($19.5k) Bal. of loan ($15,550), Shares		8,863,636
Stock issued for loan conv. Asher (3/20/14) ($19.5k) Bal. of loan ($15,550), Amount		$ 8,864	10,636					19,500
Stock issued for loan conv. RdWd III (3/24/14) ($13,187) Bal of loan ($37,136), Shares		11,081,400
Stock issued for loan conv. RdWd III (3/24/14) ($13,187) Bal of loan ($37,136), Amount		$ 11,081	2,106					13,187
Stock issued for loan conv. Asher (3/25/14) ($11.4k) Bal. of loan ($4,150), Shares		6,000,000
Stock issued for loan conv. Asher (3/25/14) ($11.4k) Bal. of loan ($4,150), Amount		$ 6,000	5,400					11,400
Stock issued for loan conv. Asher (3/28/14) ($4,150) Bal. of loan ($0), Shares		2,766,667
Stock issued for loan conv. Asher (3/28/14) ($4,150) Bal. of loan ($0), Amount		$ 2,767	1,383					4,150
Stock issued for loan conv. RdWd III (3/28/14) ($6,642) Bal of loan ($30,495), Shares		11,652,000
Stock issued for loan conv. RdWd III (3/28/14) ($6,642) Bal of loan ($30,495), Amount		$ 11,652	(5,010)					6,642
Stock issued for loan conv. Blk Mtn (4/1/14) ($15k) Bal of loan ($30.5), Shares		17,647,059
Stock issued for loan conv. Blk Mtn (4/1/14) ($15k) Bal of loan ($30.5), Amount		$ 17,647	(2,647)					15,000
Stock issued for loan conv. JMJ (4/2/14) ($7,038) Bal of loan ($32,384), Shares		6,900,000
Stock issued for loan conv. JMJ (4/2/14) ($7,038) Bal of loan ($32,384), Amount		$ 6,900	138					7,038
Stock issued for loan conv. RdWd III (4/2/14) ($6,996) Bal of loan ($23,499), Shares		12,273,600
Stock issued for loan conv. RdWd III (4/2/14) ($6,996) Bal of loan ($23,499), Amount		$ 12,273	(5,277)					6,996
Stock issued for loan conv. RdWd III (4/8/14) ($7,363) Bal of loan ($16,136), Shares		12,916,695
Stock issued for loan conv. RdWd III (4/8/14) ($7,363) Bal of loan ($16,136), Amount		$ 12,917	(5,554)					7,363
Stock issued for loan conv. Blk Mtn (4/10/14) ($15k) Bal of loan ($15.5), Shares		17,647,059
Stock issued for loan conv. Blk Mtn (4/10/14) ($15k) Bal of loan ($15.5), Amount		$ 17,647	(2,647)					15,000
Stock issued for loan conv. JMJ (4/10/14) ($32,384) Bal of loan ($0), Shares		31,749,235
Stock issued for loan conv. JMJ (4/10/14) ($32,384) Bal of loan ($0), Amount		$ 31,749	635					32,384
Stock issued for loan conv. RdWd III (4/10/14) ($7,748) Bal of loan ($8,388), Shares		13,593,400
Stock issued for loan conv. RdWd III (4/10/14) ($7,748) Bal of loan ($8,388), Amount		$ 13,593	(5,845)					7,748
Stock issued for loan conv. JSJ (4/10/14) ($4,088) Bal of loan ($20,812), Shares		10,220,000
Stock issued for loan conv. JSJ (4/10/14) ($4,088) Bal of loan ($20,812), Amount		$ 10,220	(6,132)					4,088
Stock issued for loan conv. RdWd III (4/16/14) ($8,367) Bal of loan ($3,054), Shares		14,678,154
Stock issued for loan conv. RdWd III (4/16/14) ($8,367) Bal of loan ($3,054), Amount		$ 14,678	(6,311)					8,367
Stock issued for loan conv. Blk Mtn (4/16/14) ($15.5k) Bal of loan ($0), Shares		15,500,000
Stock issued for loan conv. Blk Mtn (4/16/14) ($15.5k) Bal of loan ($0), Amount		$ 15,500	0					15,500
Stock issued for interest on JMJ loan dated 8/7/13 (4/23/14), Shares		10,900,000
Stock issued for interest on JMJ loan dated 8/7/13 (4/23/14), Amount		$ 10,900	0					10,900
Stock issued for loan conv. JSJ (4/29/14) ($14,009) Bal of loan ($20,812), Shares		22,716,552
Stock issued for loan conv. JSJ (4/29/14) ($14,009) Bal of loan ($20,812), Amount		$ 22,717	(8,708)					14,009
Stock issued for BF Science Investment 5/5/14 $.003, Shares		15,000,000
Stock issued for BF Science Investment 5/5/14 $.003, Amount		$ 15,000	30,000					45,000
Stock issued for loan conv. Iconic (5/6/14) ($15K) Bal of loan ($15k), Shares		30,000,000
Stock issued for loan conv. Iconic (5/6/14) ($15K) Bal of loan ($15k), Amount		$ 30,000	(15,000)					15,000
Stock issued for loan conv. RdWd III (5/6/14) ($8,367) Bal of loan ($0), Shares		4,492,470
Stock issued for loan conv. RdWd III (5/6/14) ($8,367) Bal of loan ($0), Amount		$ 4,492	(1,418)					3,074
Stock issued for loan conv. Iconic (5/14/14) ($16,533K) Bal of loan ($0k), Shares		33,065,760
Stock issued for loan conv. Iconic (5/14/14) ($16,533K) Bal of loan ($0k), Amount		$ 33,065	(16,532)					16,533
Stock issued for loan conv. JSJ (5/14/14) ($8,516) Bal of loan (0), Shares		15,483,636
Stock issued for loan conv. JSJ (5/14/14) ($8,516) Bal of loan (0), Amount		$ 15,483	(6,967)					8,516
Stock issued for consulting to Meadow Grove (May 27 ,2014)$.0023, Shares		15,000,000
Stock issued for consulting to Meadow Grove (May 27 ,2014)$.0023, Amount		$ 15,000	15,000					30,000
Stock issued for loan conv. Asher (5/28/14) ($11.4k) Bal. of loan ($4,150), Shares		17,545,455
Stock issued for loan conv. Asher (5/28/14) ($11.4k) Bal. of loan ($4,150), Amount		$ 17,545	1,755					19,300
Stock issued for loan conv. Iconic (5/29/14) ($15K) Bal of loan ($0k), Shares		37,500,000
Stock issued for loan conv. Iconic (5/29/14) ($15K) Bal of loan ($0k), Amount		$ 37,500	$ (22,500)					15,000
Stock issued for loan conv. Iconic (5/29/14) ($15K) Bal of loan ($0k), Shares		17,600,000
Stock issued for loan conv. Iconic (5/29/14) ($15K) Bal of loan ($0k), Amount		$ 17,602						17,601
Stock cancel for loan conv. JSJ (5/14/14) ($8,516) Bal of loan (8,516), Shares		(15,483,636)
Stock cancel for loan conv. JSJ (5/14/14) ($8,516) Bal of loan (8,516), Amount		$ (15,483)	$ 6,967					(8,516)
Stock issued for loan conv. JSJ (6/3/14) ($8,734) Bal loan (0) Replace 5/14/14, Shares		19,408,888
Stock issued for loan conv. JSJ (6/3/14) ($8,734) Bal loan (0) Replace 5/14/14, Amount		$ 19,409	(10,675)					8,734
Stock issued for loan conv. Asher (6/4/14) ($7,300) Bal. of loan ($0), Shares		8,111,111
Stock issued for loan conv. Asher (6/4/14) ($7,300) Bal. of loan ($0), Amount		$ 8,111	(811)					7,300
Stock issued for loan conv. Gel Prop. (6/11/14) ($7.5k) Bal. of loan ($27.5), Shares		14,423,077
Stock issued for loan conv. Gel Prop. (6/11/14) ($7.5k) Bal. of loan ($27.5), Amount		$ 14,423	(6,923)					7,500
Stock issued for loan conv. Gel Prop. (6/20/14) ($5k) Bal. of loan ($22.5), Shares		11,363,636
Stock issued for loan conv. Gel Prop. (6/20/14) ($5k) Bal. of loan ($22.5), Amount		$ 11,364	(6,364)					5,000
Stock issued for loan conv. JMJ (6/24/14) ($14.4k) Bal of loan ($47,924), Shares		20,000,000
Stock issued for loan conv. JMJ (6/24/14) ($14.4k) Bal of loan ($47,924), Amount		$ 20,000	(5,600)					14,400
Stock issued for consulting to Meadow Grove (6/25/14)$.0023 ($.0011), Shares		13,200,479
Stock issued for consulting to Meadow Grove (6/25/14)$.0023 ($.0011), Amount		$ 13,200	1,321					14,521
Stock issued for loan conv. Gel Prop. (6/26/14) ($5k) Bal. of loan ($17.5), Shares		12,500,000
Stock issued for loan conv. Gel Prop. (6/26/14) ($5k) Bal. of loan ($17.5), Amount		$ 12,500	(7,500)					5,000
Stock issued for loan conv. Iconic (6/30/14) ($16,730) Bal of loan ($0k), Shares		66,920,560
Stock issued for loan conv. Iconic (6/30/14) ($16,730) Bal of loan ($0k), Amount		$ 66,921	(50,191)					16,730
Stock issued for loan conv. Gel Prop. (6/30/14) ($5.1k) Bal. of loan ($12.4k), Shares		12,750,000
Stock issued for loan conv. Gel Prop. (6/30/14) ($5.1k) Bal. of loan ($12.4k), Amount		$ 12,750	(7,650)					5,100
Stock issued for loan conv. LG Cap. (7/2/14) ($11,509) Bal. of loan ($39k), Shares		28,771,780
Stock issued for loan conv. LG Cap. (7/2/14) ($11,509) Bal. of loan ($39k), Amount		$ 28,772	(17,263)					11,509
Stock issued for loan conv. Gel Prop. (7/10/14) ($8k) Bal. of loan ($4.4k), Shares		28,571,429
Stock issued for loan conv. Gel Prop. (7/10/14) ($8k) Bal. of loan ($4.4k), Amount		$ 28,571	(20,571)					8,000
Stock issued for loan conv. Asher (7/14/14) ($15k) Bal. of loan ($22.5k), Shares		34,090,909
Stock issued for loan conv. Asher (7/14/14) ($15k) Bal. of loan ($22.5k), Amount		$ 34,091	(19,091)					15,000
Stock issued for loan conv. LG Cap. (7/14/14) ($8,906) Bal. of loan ($30.5k), Shares		31,807,632
Stock issued for loan conv. LG Cap. (7/14/14) ($8,906) Bal. of loan ($30.5k), Amount		$ 31,807	(22,901)					8,906
Stock issued for loan conv. Asher (7/14/14) ($15k) Bal. of loan ($7.5k), Shares		42,857,143
Stock issued for loan conv. Asher (7/14/14) ($15k) Bal. of loan ($7.5k), Amount		$ 42,857	(27,857)					15,000
Stock issued for loan conv. Gel Prop. (7/18/14) ($4.4k) Bal. of loan (0), Shares		26,660,667
Stock issued for loan conv. Gel Prop. (7/18/14) ($4.4k) Bal. of loan (0), Amount		$ 26,661	(22,261)					4,400
Stock issued for loan conv. Asher (7/17/14) ($9k) Bal. of loan (0), Shares		31,034,483
Stock issued for loan conv. Asher (7/17/14) ($9k) Bal. of loan (0), Amount		$ 31,034	(22,034)					9,000
Stock issued for loan conv. LG Cap. (7/25/14) ($5,253) Bal. of loan ($25.5k), Shares		32,832,191
Stock issued for loan conv. LG Cap. (7/25/14) ($5,253) Bal. of loan ($25.5k), Amount		$ 32,832	(27,579)					5,253
Stock issued for loan conv.LG Cap. (7/31/14) ($8k) Bal. of loan ($17.5k), Shares		52,630,136
Stock issued for loan conv.LG Cap. (7/31/14) ($8k) Bal. of loan ($17.5k), Amount		$ 52,630	(44,209)					8,421
Stock issued for loan conv. JMJ (7/31/14) ($9,840) Bal. of loan ($38,084), Shares		41,000,000
Stock issued for loan conv. JMJ (7/31/14) ($9,840) Bal. of loan ($38,084), Amount		$ 41,000	(31,160)					9,840
Stock issued for loan conv. LG Cap.. (8/4/14) ($9,497) Bal. of loan ($8.6k), Shares		59,358,732
Stock issued for loan conv. LG Cap.. (8/4/14) ($9,497) Bal. of loan ($8.6k), Amount		$ 59,359	(49,862)					9,497
Stock issued for loan conv. LG Cap.. (8/6/14) ($9,065) Bal. of loan ($0), Shares		56,659,863
Stock issued for loan conv. LG Cap.. (8/6/14) ($9,065) Bal. of loan ($0), Amount		$ 56,660	(47,594)					9,066
Stock issued for loan conv. JMJ (8/7/14) ($13,680) Bal. of loan ($24,404), Shares		57,000,000
Stock issued for loan conv. JMJ (8/7/14) ($13,680) Bal. of loan ($24,404), Amount		$ 57,000	(43,320)					13,680
Stock issued to Shel. Davis for loan repayment(8/13/14) (41,102), Shares		140,000,000
Stock issued to Shel. Davis for loan repayment(8/13/14) (41,102), Amount		$ 140,000	(98,898)					41,102
Stock issued for loan conv. Asher (8/14/14) ($15k) Bal. of loan (12.5k), Shares		57,692,308
Stock issued for loan conv. Asher (8/14/14) ($15k) Bal. of loan (12.5k), Amount		$ 57,692	(42,692)					15,000
Stock issued for loan conv. JMJ (8/18/14) ($14,040) Bal. of loan ($10,364), Shares		78,000,000
Stock issued for loan conv. JMJ (8/18/14) ($14,040) Bal. of loan ($10,364), Amount		$ 78,000	(63,960)					14,040
Stock issued for loan conv. LG (8/29/14)Bal $24,575, Shares		62,753,278
Stock issued for loan conv. LG (8/29/14)Bal $24,575, Amount		$ 62,753	(58,047)					4,706
Stock issued for loan conv. Asher (8/16/14) ($15,374) Bal. of loan (0), Shares		59,130,435
Stock issued for loan conv. Asher (8/16/14) ($15,374) Bal. of loan (0), Amount		$ 59,130	(43,756)					15,374
Stock issued for loan conv. JMJ (9/4/14) ($14,04) Bal. of loan ($0), Shares		70,000,000
Stock issued for loan conv. JMJ (9/4/14) ($14,04) Bal. of loan ($0), Amount		$ 70,000	(57,400)					12,600
Stock issued for loan conv. Iconic (9/4/14) ($8,538) Bal. of loan ($21,462), Shares		170,760,000
Stock issued for loan conv. Iconic (9/4/14) ($8,538) Bal. of loan ($21,462), Amount		$ 170,760	(162,222)					8,538
Stock issued for loan conv. LG (9/12/14)Bal $24,575, Shares		78,759,945
Stock issued for loan conv. LG (9/12/14)Bal $24,575, Amount		$ 78,760	(74,822)					3,938
Stock issued for loan conv. Iconic (9/19/14) ($8,538) Bal. of loan ($23,276), Shares		170,760,000
Stock issued for loan conv. Iconic (9/19/14) ($8,538) Bal. of loan ($23,276), Amount		$ 170,760	(162,222)					8,538
Stock issued for loan conv. JSJ (9/19/14) ($4,692) Bal. of loan ($27,231), Shares		93,841,481
Stock issued for loan conv. JSJ (9/19/14) ($4,692) Bal. of loan ($27,231), Amount		$ 93,841	(89,149)					4,692
Stock issued for loan conv. LG (9/19/14) ($5,014) Bal of loan ( $16,900), Shares		100,271,400
Stock issued for loan conv. LG (9/19/14) ($5,014) Bal of loan ( $16,900), Amount		$ 100,271	(95,257)					5,014
Stock issued for loan conv. JMJ (9/19/14) ($12K) Bal of loan ( $50,222), Shares		100,000,000
Stock issued for loan conv. JMJ (9/19/14) ($12K) Bal of loan ( $50,222), Amount		$ 100,000	(88,000)					12,000
Stock issued for loan conv. JSJ (9/23/14) ($4,922) Bal. of loan ($27,231), Shares		98,439,714
Stock issued for loan conv. JSJ (9/23/14) ($4,922) Bal. of loan ($27,231), Amount		$ 98,440	(93,518)					4,922
Stock issued for loan conv. JSJ (10/1/14) ($2,582) Bal. of loan ($19,828), Shares		103,263,260
Stock issued for loan conv. JSJ (10/1/14) ($2,582) Bal. of loan ($19,828), Amount		$ 103,263	(100,681)					2,582
Stock issued for loan conv. Iconic (10/114) ($6,633) Bal. of loan ($21,462), Shares		265,320,000
Stock issued for loan conv. Iconic (10/114) ($6,633) Bal. of loan ($21,462), Amount		$ 265,320	(258,687)					6,633
Stock issued for loan conv. JMJ (10/1//14) ($6.3K) Bal of loan ( $41,686), Shares		105,000,000
Stock issued for loan conv. JMJ (10/1//14) ($6.3K) Bal of loan ( $41,686), Amount		$ 105,000	(98,700)					6,300
Stock issued for loan conv. Redwd III (10/1//14) ($2,680) Bal of loan ( $47,320), Shares		133,984,700
Stock issued for loan conv. Redwd III (10/1//14) ($2,680) Bal of loan ( $47,320), Amount		$ 133,985	(131,305)					2,680
Stock issued for loan conv. Redwd III (10/1//14) ($2,680) Bal of loan ( $47,320), Shares		141,004,800
Stock issued for loan conv. Redwd III (10/1//14) ($2,680) Bal of loan ( $47,320), Amount		$ 141,005	(138,185)					2,820
Stock issued for loan conv. KBM (10/16//14) ($3,225) Bal of loan ( $39,275), Shares		64,500,000
Stock issued for loan conv. KBM (10/16//14) ($3,225) Bal of loan ( $39,275), Amount		$ 64,500	(61,275)					3,225
Stock issued for loan conv. KBM (10/16//14) ($4,390) Bal of loan ( $34,885), Shares		87,800,000
Stock issued for loan conv. KBM (10/16//14) ($4,390) Bal of loan ( $34,885), Amount		$ 87,800	(83,410)					4,390
Stock issued for loan conv. WHC (10/16//14) ($4,624) Bal of loan ( $48,376), Shares		92,480,000
Stock issued for loan conv. WHC (10/16//14) ($4,624) Bal of loan ( $48,376), Amount		$ 92,480	(87,856)					4,624
Stock issued for loan conv. Tonaquint (10/16//14) ($4,393) Bal of loan ( $48,376), Shares		175,750,000
Stock issued for loan conv. Tonaquint (10/16//14) ($4,393) Bal of loan ( $48,376), Amount		$ 175,750	(171,356)					4,394
Stock issued for loan conv. KBM (10/120//14) ($7,615) Bal of loan ( $27,220), Shares		152,300,000
Stock issued for loan conv. KBM (10/120//14) ($7,615) Bal of loan ( $27,220), Amount		$ 152,300	(144,685)					7,615
Stock issued for loan conv. Redwd III (10/20//14) ($2,968) Bal of loan ( $41,532), Shares		148,392,800
Stock issued for loan conv. Redwd III (10/20//14) ($2,968) Bal of loan ( $41,532), Amount		$ 148,393	(145,425)					2,968
Stock issued for loan conv. LG (10/30/14) ($3,687) Bal of loan ( $13,400), Shares		184,359,000
Stock issued for loan conv. LG (10/30/14) ($3,687) Bal of loan ( $13,400), Amount		$ 184,359	(180,672)					3,687
Stock issued for loan conv. KBM (11/10/14) ($7,615) Bal of loan ( $19,655), Shares		152,300,000
Stock issued for loan conv. KBM (11/10/14) ($7,615) Bal of loan ( $19,655), Amount		$ 152,300	(144,685)					7,615
Stock issued for loan conv. Iconic (11/10//14) ($8,105) Bal of loan ( $8,538), Shares		324,186,800
Stock issued for loan conv. Iconic (11/10//14) ($8,105) Bal of loan ( $8,538), Amount		$ 324,187	(316,082)					8,105
Stock issued for loan conv. WHC (11/19/14) ($5,376) Bal of loan ( $43,000), Shares		107,520,000
Stock issued for loan conv. WHC (11/19/14) ($5,376) Bal of loan ( $43,000), Amount		$ 107,520	(102,144)					5,376
Stock issued for loan conv. KBM (11/19/14) ($7615) Bal of loan ( $12,040), Shares		152,300,000
Stock issued for loan conv. KBM (11/19/14) ($7615) Bal of loan ( $12,040), Amount		$ 152,300	(144,685)					7,615
Stock issued for loan conv. Redwd III (11/19/14) ($3,123) Bal of loan ( $38,409), Shares		156,167,800
Stock issued for loan conv. Redwd III (11/19/14) ($3,123) Bal of loan ( $38,409), Amount		$ 156,168	(153,045)					3,123
Stock issued for loan conv. LG (11/1914) ($4,443) Bal of loan ( $9,200), Shares		222,151,000
Stock issued for loan conv. LG (11/1914) ($4,443) Bal of loan ( $9,200), Amount		$ 222,151	(217,708)					4,443
Stock issued for loan conv. Iconic (11/20//14) ($5,207) Bal of loan ( $49,793), Shares		212,530,612
Stock issued for loan conv. Iconic (11/20//14) ($5,207) Bal of loan ( $49,793), Amount		$ 212,531	(207,324)					5,207
Stock issued for loan conv. LG (12/1/14) ($4,667) Bal of loan ( $4,800), Shares		233,356,500
Stock issued for loan conv. LG (12/1/14) ($4,667) Bal of loan ( $4,800), Amount		$ 233,357	(228,690)					4,667
Stock issued for loan conv. Redwd III (12/314) ($3,287) Bal of loan ( $35,286), Shares		164,350,200
Stock issued for loan conv. Redwd III (12/314) ($3,287) Bal of loan ( $35,286), Amount		$ 164,350	(161,063)					3,287
Stock issued for loan conv. KBM (12/5/14) ($11,400) Bal of loan ( $640), Shares		228,000,000
Stock issued for loan conv. KBM (12/5/14) ($11,400) Bal of loan ( $640), Amount		$ 228,000	(216,600)					11,400
Stock issued for loan conv. Iconic (12/10/14) ($3,148) Bal of loan ( $46,645), Shares		128,482,577
Stock issued for loan conv. Iconic (12/10/14) ($3,148) Bal of loan ( $46,645), Amount		$ 128,483	(125,335)					3,148
Stock issued for loan conv. WHC (12/10/14) ($4,800) Bal of loan ( $38,200), Shares		200,000,000
Stock issued for loan conv. WHC (12/10/14) ($4,800) Bal of loan ( $38,200), Amount		$ 200,000	(195,200)					4,800
Stock issued for loan conv. Tonaquint (11/10//14) ($3,937) Bal of loan ( $44,309), Shares		157,500,000
Stock issued for loan conv. Tonaquint (11/10//14) ($3,937) Bal of loan ( $44,309), Amount		$ 157,500	(153,563)					3,937
Stock issued for loan conv. JSJ (12/16/14) ($7,698) Bal. of loan ($12,130), Shares		307,937,698
Stock issued for loan conv. JSJ (12/16/14) ($7,698) Bal. of loan ($12,130), Amount		$ 307,938	(300,240)					7,698
Stock issued for loan conv. JMJ (12/22/14) ($19,080) Bal of loan ( $24,842), Shares		318,000,000
Stock issued for loan conv. JMJ (12/22/14) ($19,080) Bal of loan ( $24,842), Amount		$ 318,000	(298,920)					19,080
Thomas Kidd - , Shares		240,000,000
Thomas Kidd - , Amount		$ 240,000	(216,000)					24,000
Stock issued for loan conv. Adar (12/30/14) ($3,846) Bal of loan ( $48,154), Shares		153,846,000
Stock issued for loan conv. Adar (12/30/14) ($3,846) Bal of loan ( $48,154), Amount		$ 153,846	(150,000)					3,846
Stock issued for loan conv. KBM (12/31/14) ($2,340) Bal of loan ( $0), Shares		46,800,000
Stock issued for loan conv. KBM (12/31/14) ($2,340) Bal of loan ( $0), Amount		$ 46,800	(44,460)					2,340
Stock issued for loan conv. KBM (12/31/14) ($9,060) Bal of loan ($23,440), Shares		181,200,000
Stock issued for loan conv. KBM (12/31/14) ($9,060) Bal of loan ($23,440), Amount		$ 181,200	(172,140)					9,060
Stock issued for loan conv. LG (12/31/14) ($5,121) Bal of loan ( $4,800), Shares		256,044,000
Stock issued for loan conv. LG (12/31/14) ($5,121) Bal of loan ( $4,800), Amount		$ 256,044	(250,923)					5,121
Stock issued for loan conv. Tonaquint (1/12/14) ($4k) Bal of loan ( $40,559), Shares		160,000,000
Stock issued for loan conv. Tonaquint (1/12/14) ($4k) Bal of loan ( $40,559), Amount		$ 160,000	(156,000)					4,000
Stock issued for loan conv. KBM (2/16/15) ($14,030) Bal of loan ( $9,410), Shares		280,600,000
Stock issued for loan conv. KBM (2/16/15) ($14,030) Bal of loan ( $9,410), Amount		$ 280,600	(266,570)					14,030
Currency translation							$ (37,902)	(37,902)
Unmortized disc. Accretion			126,403					126,403
Net loss					(3,020,655)			(3,020,655)
Ending Balance, Shares at May. 31, 2015	50,000	8,805,932,169				(124,819,802)
Ending Balance, Amount at May. 31, 2015	$ 50	$ 8,805,105	36,219,642	858,000	49	$ (124,820)	(126,453)	(3,330,440)
Beginning Balance, Amount at May. 31, 2014								(965,905)
Net loss								(3,020,655)
Ending Balance, Shares at May. 31, 2015	50,000	8,805,932,169				(124,819,802)
Ending Balance, Amount at May. 31, 2015	$ 50	$ 8,805,105	$ 36,219,642	$ 858,000	$ 49	$ (124,820)	$ (126,453)	$ (3,330,440)

Description of Business

Description of Business	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 1 - Description of Business	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. The Company devotes most of its time developing its products. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement. On February 29, 2012, the Company formed a new wholly owned subsidiary, Solawerks, Inc., in the State of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solawerk's current focus is to develop and distribute the IR Charger, which is a combined cover and charging case for Apple's iPad, and Samsung products. Solawerks competes in a market that also includes 3D Systems (DDD), Dell ( DELL ), and Hewlett Packard (HPQ). Currently the charter is in default with the Secretary of State of Nevada. On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State. On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company's corporate operations based in Toronto, Ontario, Canada. On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. ("Zaktek"). Zaktek's main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone Ò On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark. On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going Concern

Going Concern	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 2 - Going Concern	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. For the period March 30, 2006 (inception) to May 31, 2015, the Company incurred net losses of $48,962,791. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders. These factors raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 3 - Summary of Significant Accounting Policies	RECENT ACCOUNTNG PRONOUNCEMENTS In June 2014, The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation" ("ASU 2014-10"). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the years ended May 31, 2015 and 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows. PRINCIPLES OF CONSOLIDATION The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solarwerks, Inc., and MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3. FOREIGN CURRENCY TRANSLATION AND TRANSACTION GAINS AND LOSSES We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders' deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of operations related to the recurring measurement and settlement of such transactions. The translation rate for the Canadian dollar as of May 31, 2015 was $0.80. U SE OF ESTIMATES The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates. The primary management estimates included in these consolidated financial statements are the fair value of Company stock tendered in various non-monetary transactions and the fair value of the derivative liability for convertible notes payable. CASH AND CASH EQUIVALENTS The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At May 31, 2015 and 2014, cash and cash equivalents consisted only of cash in the bank, or amounts due to bank. Loan Receivable From Consultant The loan receivable from consultant is a short term, less than one year note, due July 15, 2015, and is non-interest bearing. NET LOSS PER COMMON SHARE Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation. For the years ended May 31, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive: Common Shares Equivalent Years Ended May 31, 2015 2014 Convertible notes payable 23,613,258,824 1,568,946,386 Series A convertible preferred stock 50,000,000 50,000,000 Warrants 850,000 850,000 Total common shares equivalent 23,664,118,824 1,619,796,386 INTANGIBLE ASSETS Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets. Reclassification A reclassification has been made to the prior period consolidated balance sheet to conform to the current period presentation. This reclassification had no effect on previous reported results of operations. The Company has shown separately the amount of treasury stock from the Common stock in the consolidated balance sheet and statement of stockholders' deficit. IMPAIRMENT OF LONG-LIVED ASSETS In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. STOCK-BASED COMPENSATION The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock. ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505. RESEARCH AND DEVELOPMENT All research and development expenditures are expensed as incurred. REVENUE RECOGNITION The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Investments

Investments	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 4 - Investments	Investments consist of: May 31, 2015 May 31, 2014 Imagic Ltd. - 40% equity interest $ 1,094,166 $ 1,094,166 Barefoot Science Products & Services Inc. - 15% equity interest 50,000 50,000 Total $ 1,144,166 $ 1,144,166 The cost of the 40% equity interest in Imagic Ltd. at May 31, 2015 consists of: July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $ 697,500 December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd. 99,200 Cash payments to or for the benefit of Imagic Ltd. 147,466 Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings 150,000 Total $ 1,094,166 Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the year ended May 31, 2015. The cost of the 15% equity interest in Barefoot Science Products & Services Inc. consists of: January 25, 2013 cancellation of the Marketing and Distribution Agreement dated June 20, 2012 $ 5,000 May 14, 2014 issuance of 15,000,000 shares of DoMark common stock to Lance Todd pursuant to Agreement of Understanding dated March 27, 2014 45,000 Total $ 50,000 On January 25, 2013, the Company executed an agreement with Barefoot Science Products & Services Inc. ("Barefoot Science") which cancelled the Marketing and Distribution Agreement dated June 20, 2012 and which provided the Company a 15% equity interest in Barefoot Science. As a result, the Company recognized an impairment charge of $4,605,480 in the year ended May 31, 2013 to write off the remaining unamortized prepaid license fees at February 28, 2013 ($4,605,480) and to record the estimated fair value of the 15% equity interest in Barefoot Science at $5,000. On March 27, 2014, DoMark executed an Agreement of Understanding with Barefoot Science and its other owner Lanee Todd. Among other things, the Agreement of Understanding provides for (1) DoMark's issuance of 15,000,000 shares of DoMark common stock to Lance Todd (which occurred May 14, 2014), (2) future monthly remittances of 15% of Barefoot Science's profit (as defined) to DoMark, and (3) the addition of R. Brentwood Strasler (DoMark's non-executive Chairman) to Barefoot Science's Board of Directors. Barefoot Science has developed a patented foot strengthening system through insertion of an insole system or by incorporation right into the design of shoes. Barefoot Science shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.

Licensing Agreement With Wazzam

Licensing Agreement With Wazzamba Sa	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 5 - Licensing Agreement With Wazzamba Sa	During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the "Licensor"). The agreement provides the Company an exclusive license to use certain technology (which permits third-party subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor "Flat Fee" compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus "Revenue Share" compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party. At February 28, 2014, the Company recorded this Licensing Agreement and the related "Flat Fee" liability as an intangible asset and liability in the amount of $300,000. In the three months ended May 31, 2014, the Company paid $75,075 of the first $100,000 "Flat Fee" installment due the Licensor under the agreement. The other $24,925 due is presently past due. The Company is currently in negotiations with the Licensor to have its rights pursuant to the Licensing Agreement converted into an equity interest in a new entity to be owned by both the Company and the Licensor. The new entity would have worldwide rights to Licensor's technology now entitled "Monetizer 101". Licenses, net of accumulated amortization, consist of: May 31, May 31, 2015 2014 Wazzamba, S.A. $ 300,000 $ 300,000 Bioharmonics 10,000 10,000 Subtotal 310,000 310,000 Accumulated amortization (268,338 ) (60,898 ) Total $ 41,662 $ 249,102

Note Payable To Bank

Note Payable To Bank	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 6 - Note Payable To Bank	In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $198,000 bears interest at a rate at 10% payable monthly, is due in full on December 31, 2014, and is secured by a Common Stock Reserve (as defined in the Loan Agreement), a Guaranty of Payment from the Company's chief financial officer and his wife, and certain real property owned by the Company's chief financial officer and his wife. Currently the loan is in default and management is working on a loan modification with the Lender. Past due interest of $18,000 was added to principal loan of $180,000.

Loans Payable To Related Partie

Loans Payable To Related Parties, Consultants, And Stockholders	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 7 - Loans Payable To Related Parties, Consultants, And Stockholders	Loans payable to related parties, consultants, and stockholders consist of: May 31, May 31, 2015 2014 Consultant and stockholder $ 80,796 $ 90,402 Chief executive officer/Pres. of DoMark International, Inc. 45,850 47,500 Non Exec. Chairman of Board of DoMark International, Inc. - 11,875 Chairman of Barefoot Science and affiliate 21,500 21,500 Consultant 16,097 16,097 Consultant 17,085 1,598 Consultant 8,600 - Total $ 189,928 $ 188,972 The loans payable to related parties, consultants, and stockholders are informal and do not provide for interest or a stated maturity date.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 8 - Convertible Notes Payable	At May 31, 2015 the convertible notes payable consisted of ; Date of Interest Maturity Principal Unamortized Net Note Noteholder Rate Date Amount Discount Note 12/19/13 JMJ Financial Inc 10 % 12/19/14 $ 24,842 (i) $ 0 $ 24,842 3/7/14 JSJ Investments, Inc. 12 % 10/7/14 12,130 (g) 0 12,130 3/28/14 Redwood Fund III 10 % 9/28/14 35,122 (f) 0 35,122 3/18/14 Redwood Managament, LLC. 10 % 9/28/14 50,000 (g) 0 50,000 4/14/14 WHC Capital, Inc 12 % 10/14/14 38,200 (i) 0 38,200 4/11/14 Tonaquint, Inc 12 % 10/11/14 40,559 (g) 0 40,559 4/24/14 JSJ Investments, Inc. 12 % 10/24/14 50,000 (g) 0 50,000 5/12/14 Iconic Holdings, LLC 10 % 11/12/14 46,645 (g) 0 46,645 5/16/14 KBM Worldwide, Inc 8 % 11/14/14 9,410 (l) 0 9,410 6/3/14 Adar Bays, Inc 8 % 12/12/14 48,654 (g) 0 48,654 6/23/14 JMJ Financial Inc 10 % 12/23/14 50,000 (i) 0 50,000 7/3/14 LG Capital, Inc 8 % 1/3/15 36,750 (a) 0 36,750 7/22/14 Redwood Fund III 10 % 1/22/15 100,082 (g) 0 100,082 8/14/14 KBM Worldwide, Inc 8 % 2/14/15 27,500 (l) 0 27,500 10/8/14 LG Capital, Inc 8 % 4/8/15 3,000 (a) 0 3,000 12/2/14 Tonaquint, Inc 12 % 6/2/15 10,000 (g) 6,849 3,151 12/5/14 LG Capital, Inc. 8 % 6/5/15 9,500 (a) 6,462 3038 1/7/15 LG Capital Inc 8 % 7/7/15 22,500 (a) 20,763 1737 3/15/15 Curran 10 % 3/15/15 25,000 (l) 24,864 136 Totals $ 639,894 $ 58,938 $ 580,956 Legend (a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion. (b) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion. (c) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion. (d) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion. (e) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion. (f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion. (g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the average of the three lowest bid prices during the 20 trading days prior to the notice of conversion. (h) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 20% of the lowest trading price during the 20 trading days prior to the notice of conversion. (i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest trading price during the 20 trading days prior to the notice of conversion. (j) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 15 trading days prior to the notice of conversion.

Stockholders Equity

Stockholders Equity	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 9 - Stockholders Equity	Series A Convertible Preferred Stock Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock. Common Stock Issuances On June 17, 2013, the Company issued 2,500,000 shares of common stock in satisfaction of a $50,000 loan payable. On June 29, 2013, the Company issued 2,500,000 shares of common stock (valued at $250,000) to a consultant for services rendered. On July 5, 2013, the Company issued 250,000 shares of common stock (valued at $22,500) to a consultant for website development services. On July 9, 2013, the Company issued 75,000 shares of common stock (valued at $6,675) to a consultant for services rendered. On July 17, 2013, the Company issued 500,000 shares of common stock (valued at $41,650) to a consultant for investor relations services. On July 22, 2013, the Company issued 2,874,550 shares of common stock in satisfaction of a $57,491 loan payable. On July 22, 2013, the Company issued 7,500,000 shares of common stock (valued at $697,500) in connection with the acquisition of a 19% equity interest in Imagic Ltd. See Note 4. On August 15, 2013, the Company issued 500,000 shares of common stock (valued at $35,500) to Bioharmonics Technologies Corp. in connection with the acquisition of certain inventions and related patents and patent applications. On August 26, 2013, the Company issued 2,000,000 shares of common stock (valued at $133,000) to a consultant for services rendered. On August 28, 2013, the Company issued 1,114,206 shares of common stock to Asher Enterprises, inc. in satisfaction of $14,000 principal amount of convertible notes payable and $26,000 of fees. On September 18, 2013, the Company issued 856,164 shares of common stock to Asher Enterprises, Inc. in satisfaction of $25,000 principal amount of convertible notes payable. On October 9, 2013, the Company issued 1,000,000 shares of common stock (valued at $45,600) to a consultant for services rendered. On October 10, 2013, the Company issued 250,000 shares of common stock (valued at $12,500) to a consultant for services rendered. On November 4, 2013, the Company issued 903,261 shares of common stock to Asher Enterprises, Inc. in satisfaction of $14,000 principal amount of convertible notes payable and $500 of costs. On November 4, 2013, the Company issued 1,153,846 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of principal amount of convertible notes payable. On November 4, 2013, the Company issued 3,500,000 shares of common stock in satisfaction of a $52,500 loan payable. On November 12, 2013, the Company issued 1,630,435 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of convertible notes payable. On November 14, 2013, the Company issued 3,999,200 shares of common stock to Iconic Holdings, LLC in satisfaction of $13,197 principal amount of convertible notes payable. On November 15, 2013 the Company issued 175,000 shares of common stock (valued at $1,750) to a consultant for services rendered. On November 19, 2013, the Company issued 3,456,597 shares of common stock to Asher Enterprises, Inc. in satisfaction of $2,500 principal amount of convertible notes payable and $17,548 of costs. On November 19, 2013, the Company issued 8,850,572 shares of common stock to Iconic Holdings, LLC in satisfaction of $22,126 principal amount of convertible notes payable. Effective December 3, 2013, the Company issued 8,000,000 shares of common stock (valued at $99,200) to Meadow Grove Ltd. in connection with the acquisition of a 9% equity interest in Imagic Ltd. See Note 4. On December 4, 2013, the Company issued 7,072,457 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,852 principal amount of convertible notes payable. On December 18, 2013, the Company issued 5,445,005 shares of common stock to Iconic Holdings, LLC in satisfaction of $11,435 principal amount of convertible notes payable. On December 26, 2013 the Company issued 4,166,667 shares of common stock to Asher Enterprises, Inc. in satisfaction of $20,000 principal amount of convertible notes payable. On December 30, 2013, the Company issued 4,791,667 shares of common stock to Asher Enterprises, Inc. in satisfaction of $23,000 principal amount of convertible notes payable. On January 6, 2014, the Company issued 1,305,556 shares of common stock to Asher Enterprises, Inc. in satisfaction of $7,050 principal amount of convertible notes payable. On January 13, 2014, the Company issued 6,198,762 shares of common stock to Iconic Holdings, LLC in satisfaction of $13,017 principal amount of convertible notes payable. On January 23, 2014, the Company issued 6,436,781 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,000 principal amount of convertible notes payable. On February 3, 2014, the Company issued 7,498,890 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,998 principal amount of convertible notes payable. On February 6, 2014, the Company issued 4,900,000 shares of common stock to JSJ Investments, Inc. in satisfaction of $17,150 principal amount of convertible notes payable. On February 11, 2014, the Company issued 3,000,000 shares of common stock to JMJ Financial Inc. in satisfaction of $10,800 principal amount of convertible notes payable. On February 11, 2014, the Company issued 4,901,960 shares of common stock to Continental Equities, LLC in satisfaction of $20,000 principal amount of convertible notes payable. On February 13, 2014, the Company issued 5,000,000 shares of common stock to Black Mountain Equities, Inc. in satisfaction of $15,000 principal amount of convertible notes payable. On February 25, 2014, the Company issued 4,000,000 shares of common stock to JMJ Financial Inc. in satisfaction of $12,000 principal amount of convertible notes payable. On February 26, 2014, the Company issued 3,278,688 shares of common stock to Continental Equities, LLC in satisfaction of $10,000 principal amount of convertible notes payable. On March 3, 2014, the Company issued 12,000,000 shares of common stock (valued at $80,400) to a consultant for services. On March 3, 2014, the Company issued 6,419,120 shares of common stock to Redwood Fund III in satisfaction of $10,913 principal amount of convertible payable. On March 6, 2014, the Company issued 6,755,135 shares of common stock to Redwood Fund III in satisfaction of $10,133 principal amount of convertible payable. On March 6, 2014, the Company issued 3,990,435 shares of common stock to JSJ Investments in satisfaction of $9,178 principal amount of convertible payable. On March 6, 2014, the Company issued 7,108,733 shares of common stock to Redwood Fund III in satisfaction of $10,663 principal amount of convertible payable. On March 17, 2014, the Company issued 5,668,934 shares of common stock (valued at $32,880) to a consultant for services. On March 17, 2014, the Company issued a total of 27,000,000 shares of common stock (valued at $156,600) to officers for services. On March 18, 2014, the Company issued 6,818,182 shares of common stock to Asher Enterprises in satisfaction of $15,000 principal amount of convertible notes payable. On March 18, 2014, the Company issued 10,053,100 shares of common stock to Redwood Fund III in satisfaction of $12,968 principal amount of convertible notes payable. On March 19, 2014, the Company issued 2,000,000 shares of common stock (valued at $9,800) to a consultant for services. On March 20, 2014, the Company issued 8,863,636 shares of common stock to Asher Enterprises in satisfaction of $19,500 principal amount of convertible notes payable. On March 24, 2014, the Company issued 11,081,400 shares of common stock to Redwood Fund III in satisfaction of $13,187 principal amount of convertible notes payable. On March 25, 2014, the Company issued 6,000,000 shares of common stock to Asher Enterprises in satisfaction of $11,400 principal amount of convertible notes payable. On March 28, 2014, the Company issued 2.766.667 shares of common stock to Asher Enterprises in satisfaction of $4,150 principal amount of convertible notes payable. On March 28, 2014, the Company issued 11,652,000 shares of common stock to Redwood Fund III in satisfaction of $6,642 principal amount of convertible notes payable. On April 1, 2014, the Company issued 17,647,059 shares of common stock to Black Mountain Equities in satisfaction of $15,000 principal amount of convertible notes payable. On April 2, 2014, the Company issued 6,900,000 shares of common stock to JMJ Financial in satisfaction of $7,038 principal amount of convertible notes payable. On April 2, 2014, the Company issued 12,273,600 shares of common stock to Redwood Fund III in satisfaction of $6,996 principal amount of convertible notes payable. On April 8, 2014, the Company issued 12,916,695 shares of common stock to Redwood Fund III in satisfaction of $7,363 principal amount of convertible notes payable. On April 10, 2014, the Company issued 17,647,059 shares of common stock to Black Mountain Equities in satisfaction of $15,000 principal amount of convertible notes payable. On April 10, 2014, the Company issued 31,749,235 shares of common stock to JMJ Financial in satisfaction of $32,384 principal amount of convertible notes payable. On April 10, 2014, the Company issued 13,593,400 shares of common stock to Redwood Fund III in satisfaction of $7,748 principal amount of convertible notes payable. On April 10, 2014, the Company issued 10,220,000 shares of common stock to JSJ Investments in satisfaction of $4,088 principal amount of convertible notes payable. On April 16, 2014, the Company issued 14,678,154 shares of common stock to Redwood Fund III in satisfaction of $8,367 principal amount of convertible notes payable. On April 16, 2014, the Company issued 15,500,000 shares of common stock to Black Mountain Equities in satisfaction of $15,500 principal amount of convertible notes payable. On April 23, 2014, the Company issued 10,900,000 shares of common stock to JMJ Financial in satisfaction of $10,900 principal amount of convertible notes payable. On April 29, 2014, the Company issued 22,716,552 shares of common stock to JSJ Investments in satisfaction of $14,009 principal amount of convertible notes payable. On May 5, 2014, the Company issued 15,000,000 shares of common stock to Barefoot Science Products & Services Inc. On May 6, 2014, the Company issued 30,000,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $15,000 principal amount of convertible payable. On May 6, 2014, the Company issued 4,492,470 shares of common stock to Redwood Fund III in satisfaction of $3,074 principal amount of convertible payable. On May 14, 2014, the Company issued 33,065,760 shares of common stock to Iconic Holdings, LLC in satisfaction of $16,533 principal amount of convertible payable. On May 14, 2014, the Company issued 15,483,636 shares of common stock to JSJ Investments in satisfaction of $8,516 principal amount of convertible notes payable. On May 27, 2014, the Company issued 15,000,000 shares of common stock (valued at $30,000) to a consultant for services. On May 28, 2014, the Company issued 17,545,455 shares of common stock to Asher Enterprises, Inc. in satisfaction of $19,300 principal amount of convertible notes payable. On May 29, 2014, the Company issued 37,500,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $15,000 principal amount of convertible notes payable. On May 29, 2014, the Company issued 17,600,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $17,600 principal amount of convertible notes payable. On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable. On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable. On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable. On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable. On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable. On December 16,, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable. On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable. On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable. On October 1, 2014, the Company issued 141,004,800 shares of common stock to Redwood Fund III, Inc. in satisfaction of $2,680 of principal amount of convertible notes payable. On October 16, 2014, the Company issued 64,500,000 shares of common stock to KBM Worldwide, Inc., Inc. in satisfaction of $3,225 principal amount of convertible notes payable. On October 16, 2014, the Company issued 87,800,000 shares of common stock to KBM Worldwide, Inc.in satisfaction of $4,390 principal amount of convertible notes payable.. On October 16, 2014, the Company issued 92,480,000 shares of common stock to WHC Captial, Inc. in satisfaction of $ 4,624 principal amount of convertible notes payable. On October 16, 2014, the Company issued 175,750,000 shares of common stock to Tonaquint, Inc. in satisfaction of $4,393 principal amount of convertible notes payable. On October 20, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable. On October 20, 2014, the Company issued 148,392,800 shares of common stock to Redwood Fund, III, Inc. in satisfaction of $2,968 principal amount of convertible notes payable. On October 30,, 2014, the Company issued 184,359,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $3,687 principal amount of convertible notes payable. On November 10, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable. On November 10, 2014 the Company issued 157,500,000 shares of common stock Tonaquint, Inc in satisfaction of $3,937 principal amount of convertible notes payable.. On November 11, 2014, the Company issued 324,186,800 shares of common stock to Iconic Holdings, LLC. in satisfaction of $8,105 principal amount of convertible notes payable. On November 19, 2014, the Company issued 107,520,000 shares of common stock to WHC Capital Inc. in satisfaction of $5,376 principal amount of convertible notes payable. On November 19, 2014, the Company issued 156,167,800 shares of common stock to KBM Worldwide, Inc in satisfaction of $7,615 principal amount of convertible noted payable. On November 19, 2014,, the Company issued 222,151,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $4,443 principal amount of convertible notes payable. On November 20, 2014, the Company issued 212,530,662 shares of common stock to Iconic Holdings, LLC in satisfaction of $5,207 principal amount of loan payable. On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable. On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable. On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable. On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable. On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable. On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable. On December 16, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable. On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable. On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 181,200,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable. On December 31, 2014, the Company issued 256,044,000 shares of common stock to LG Capital, Inc., Inc. in satisfaction of $5,121 principal amount of convertible notes payable. On January 12, 2015, 2014, the Company issued 160,000,000 shares of common stock to Tonaquint, Inc.in satisfaction of $4,000 principal amount of convertible notes payable.. On February 17, 2015, the Company issued 280,600,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $ 14,030 principal amount of convertible notes payable. Warrants to Purchase Common Stock A summary of warrant activity for the years ended May 31, 2015 and 2014 follows: Number of Warrants Weighted Average Exercise Price Outstanding May 31, 2012 - $ - Granted 850,000 0.42 Exercised - - Cancelled - - Outstanding at May 31, 2015 850,000 0.42 Granted - - Exercised - - Cancelled - - Outstanding at May 31, 2015 850,000 $ 0.42 Warrants outstanding at May 31, 2015 consist of: Date Granted Number Outstanding Exercise price Expiration Date June 1, 2012 100,000 $ 1.00 June 1, 2015 June 12, 2012 150,000 $ 1.00 June 12, 2015 June 26, 2012 100,000 $ 1.00 June 26, 2015 January 1, 2013 500,000 $ 0.01 January 1, 2016 Totals 850,000

Fair Value Measurements and Der

Fair Value Measurements and Derivative Liabiliity	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 10 - Fair Value Measurements and Derivative Liabiliity	The Compan y Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. During the year ended May 31, 2014, the Company entered into numerous convertible note agreements.Under ASC-815, the conversion options embedded in the notes payable described in Note 8 require derivate liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement. As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management's best estimate of fair value. Derivative liability — the Company's derivative liability is classified within Level 3 of the fair value hierarchy. The Company uses the Black Scholes Option Pricing Model to value its option based derivatives based upon the following assumptions: dividend yield of -0-%, volatility of 100%, risk free interest rate ranging from 0.04% to 0.13 % and an expected term equal to the remaining term of the note. The following table sets forth, by level, the fair value hierarchy the Company's derivative liabilities, from their convertible promissory notes payable, that were accounted for at fair value as of May 31, 2015 and May 31, 2014. Recurring Fair Value Measurements Level 1 Level 2 Level 3 Total Liabilities: Derivative liability – May 31, 2015 $ - $ - $ 2,564,280 $ 2,564,280 Derivative liability – May 31, 2014 $ - $ - $ 1,748,982 $ 1,748,982

Income Taxes

Income Taxes	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 11 - Income Taxes	The Company has available net operating loss carry-forwards for financial statement and federal income tax purposes. These loss carry-forwards expire if not used within 20 years from the year generated. The Company's management has decided a valuation allowance is necessary to reduce any tax benefits because the available benefits are more likely than not to expire before they can be used. The tax based accumulated deficit creates tax benefits in the amount of $5,068,598 from inception through May 31, 2015. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax liabilities and assets as of May 31, 2015 and 2014 are as follows: May 31, 2015 2014 Deferred tax assets 5,668,598 5,068,598 Valuation allowance (5,668,598 ) (5,068,598 ) Total deferred tax assets $ - $ - The valuation allowance for deferred tax assets as of May 31, 2015 and 2014 was $5,668,598 and $5,068,598, respectively. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not the deferred tax assets would not be realized as of May 31, 2015 and 2014, and maintained a full valuation allowance. Reconciliation between the statutory rate and the effective tax rate is as follows for the years ended May 31, 2015 and 2014: Federal statutory tax rate (20.0 )% Permanent differences and valuation allowance (20.0 )% Effective tax rate 0.0 %

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 12 - Commitments and Contingencies	License Agreements On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. ("Bioharmoniecs"). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging. In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 5. Employment Agreements On May 25, 2012, the Company entered into an employment agreement with its Non-Exec Chaiman of the Board, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler. The policy has not been implanted as of May 31, 2014. Mr. Strasler resigned on December 1, 2014 and was relieved of all duties and responsibilities of the Company, including but not limited to, Non-Exec Chairman and Secretary. On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Ritchie. Related Party Transactions During the current fiscal years ending May 31, 2015, and May 31, 2014 Mr. Andrew Ritchie was compensated $116,512 and $165,209. Mr. R. Brent Strasler was compensated $26,500 and $115,850 for the same period. For fiscal years ending May 31, 2015 and May 31, 2014 Mr. Andrew Ritchie was owed $47,500 for both years, and Mr. Brent Strasler was owed $0 in May 31, 2015 and $11,85 in May 31, 2014. Lease Agreement On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At May 31, 2015, the future lease commitments on this lease for the years ended May 31, are as follows: 2016 $ 58,880 2017 59,520 2018 7,936 Total $ 126,336

Subsequent Event

Subsequent Event	12 Months Ended
	May. 31, 2015
Notes to Financial Statements
Note 13 - Subsequent Event	On August 12, 2015, the Company issued 1,170,000 shares of our Series B Convertible Preferred Stock to our Chief Executive Officer, Andrew Ritchie, in full payment of $365,708 in accrued compensation owed to him and $45.850 in advances that Mr. Ritchie had made to the Company. These shares are convertible into 9,360,000,000 shares of the Company's common stock at the election of the holder. Also on August 12, 2015, the Company issued Thomas Crompton, our Chief Financial Officer , 780,000 shares of of Series B Convertible Preferred Stock in full payment of $203,121 in accrued compensation and $17,085 in advances to the Company. These shares are convertible into 6,240,000,000 shares of the Company's common stock at the election of the holder. The above issuances became effective August 13, 2015, the date of recordation of the certificate of designation of the Company's Series B Convertible Preferred Stock with the Secretary of State of Nevada. Class B Convertible Preferred Stock has voting rights equal to 51% of the voting power of the Company. Each share of Class B Convertible Preferred Stock is convertible into 8,000 shares of common stock at the election of the holder.

Summary of Significant Accoun20

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	May. 31, 2015
Summary Of Significant Accounting Policies Policies
Recent Accountng Pronouncements	In June 2014, The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation" ("ASU 2014-10"). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the years ended May 31, 2015 and 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Principles of Consolidation	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solarwerks, Inc., and MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3.
Foreign Currency Translation and Transaction Gains and Losses	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders' deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of operations related to the recurring measurement and settlement of such transactions. The translation rate for the Canadian dollar as of May 31, 2015 was $0.80.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates. The primary management estimates included in these consolidated financial statements are the fair value of Company stock tendered in various non-monetary transactions and the fair value of the derivative liability for convertible notes payable.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At May 31, 2015 and 2014, cash and cash equivalents consisted only of cash in the bank, or amounts due to bank.
Loan Receivable From Consultant	The loan receivable from consultant is a short term, less than one year note, due July 15, 2015, and is non-interest bearing.
Net Loss Per Common Share	Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation. For the years ended May 31, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive: Common Shares Equivalent Years Ended May 31, 2015 2014 Convertible notes payable 23,613,258,824 1,568,946,386 Series A convertible preferred stock 50,000,000 50,000,000 Warrants 850,000 850,000 Total common shares equivalent 23,664,118,824 1,619,796,386
Intangible Assets	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Reclassification	A reclassification has been made to the prior period consolidated balance sheet to conform to the current period presentation. This reclassification had no effect on previous reported results of operations. The Company has shown separately the amount of treasury stock from the Common stock in the consolidated balance sheet and statement of stockholders' deficit.
Impairment of Long-Lived Assets	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock Based Compensation	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock. ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Research and Development	All research and development expenditures are expensed as incurred.
Revenue Recognition	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	May. 31, 2015
Summary Of Significant Accounting Policies Tables
Net Loss Per Common Share	For the years ended May 31, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive: Common Shares Equivalent Years Ended May 31, 2015 2014 Convertible notes payable 23,613,258,824 1,568,946,386 Series A convertible preferred stock 50,000,000 50,000,000 Warrants 850,000 850,000 Total common shares equivalent 23,664,118,824 1,619,796,386

Investments (Tables)

Investments (Tables)	12 Months Ended
	May. 31, 2015
Investments Tables
Investments	Investments consist of: May 31, 2015 May 31, 2014 Imagic Ltd. - 40% equity interest $ 1,094,166 $ 1,094,166 Barefoot Science Products & Services Inc. - 15% equity interest 50,000 50,000 Total $ 1,144,166 $ 1,144,166
Cost of equity interest 40%	The cost of the 40% equity interest in Imagic Ltd. at May 31, 2015 consists of: July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $ 697,500 December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd. 99,200 Cash payments to or for the benefit of Imagic Ltd. 147,466 Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings 150,000 Total $ 1,094,166
Cost of equity interest 15%	The cost of the 15% equity interest in Barefoot Science Products & Services Inc. consists of: January 25, 2013 cancellation of the Marketing and Distribution Agreement dated June 20, 2012 $ 5,000 May 14, 2014 issuance of 15,000,000 shares of DoMark common stock to Lance Todd pursuant to Agreement of Understanding dated March 27, 2014 45,000 Total $ 50,000

Licensing Agreement With Wazz23

Licensing Agreement With Wazzamba Sa (Tables)	12 Months Ended
	May. 31, 2015
Licensing Agreement With Wazzamba Sa Tables
Licenses, net of accumulated amortization	Licenses, net of accumulated amortization, consist of: May 31, May 31, 2015 2014 Wazzamba, S.A. $ 300,000 $ 300,000 Bioharmonics 10,000 10,000 Subtotal 310,000 310,000 Accumulated amortization (268,338 ) (60,898 ) Total $ 41,662 $ 249,102

Loans Payable To Related Part24

Loans Payable To Related Parties, Consultants, And Stockholders (Tables)	12 Months Ended
	May. 31, 2015
Loans Payable To Related Parties Consultants And Stockholders Tables
Loans payable to related parties, consultants, and stockholders	Loans payable to related parties, consultants, and stockholders consist of: May 31, May 31, 2015 2014 Consultant and stockholder $ 80,796 $ 90,402 Chief executive officer/Pres. of DoMark International, Inc. 45,850 47,500 Non Exec. Chairman of Board of DoMark International, Inc. - 11,875 Chairman of Barefoot Science and affiliate 21,500 21,500 Consultant 16,097 16,097 Consultant 17,085 1,598 Consultant 8,600 - Total $ 189,928 $ 188,972

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	May. 31, 2015
Convertible Notes Payable Tables
Convertible notes payable	At May 31, 2015 the convertible notes payable consisted of ; Date of Interest Maturity Principal Unamortized Net Note Noteholder Rate Date Amount Discount Note 12/19/13 JMJ Financial Inc 10 % 12/19/14 $ 24,842 (i) $ 0 $ 24,842 3/7/14 JSJ Investments, Inc. 12 % 10/7/14 12,130 (g) 0 12,130 3/28/14 Redwood Fund III 10 % 9/28/14 35,122 (f) 0 35,122 3/18/14 Redwood Managament, LLC. 10 % 9/28/14 50,000 (g) 0 50,000 4/14/14 WHC Capital, Inc 12 % 10/14/14 38,200 (i) 0 38,200 4/11/14 Tonaquint, Inc 12 % 10/11/14 40,559 (g) 0 40,559 4/24/14 JSJ Investments, Inc. 12 % 10/24/14 50,000 (g) 0 50,000 5/12/14 Iconic Holdings, LLC 10 % 11/12/14 46,645 (g) 0 46,645 5/16/14 KBM Worldwide, Inc 8 % 11/14/14 9,410 (l) 0 9,410 6/3/14 Adar Bays, Inc 8 % 12/12/14 48,654 (g) 0 48,654 6/23/14 JMJ Financial Inc 10 % 12/23/14 50,000 (i) 0 50,000 7/3/14 LG Capital, Inc 8 % 1/3/15 36,750 (a) 0 36,750 7/22/14 Redwood Fund III 10 % 1/22/15 100,082 (g) 0 100,082 8/14/14 KBM Worldwide, Inc 8 % 2/14/15 27,500 (l) 0 27,500 10/8/14 LG Capital, Inc 8 % 4/8/15 3,000 (a) 0 3,000 12/2/14 Tonaquint, Inc 12 % 6/2/15 10,000 (g) 6,849 3,151 12/5/14 LG Capital, Inc. 8 % 6/5/15 9,500 (a) 6,462 3038 1/7/15 LG Capital Inc 8 % 7/7/15 22,500 (a) 20,763 1737 3/15/15 Curran 10 % 3/15/15 25,000 (l) 24,864 136 Totals $ 639,894 $ 58,938 $ 580,956

Stockholders Equity (Tables)

Stockholders Equity (Tables)	12 Months Ended
	May. 31, 2015
Stockholders Equity Tables
Summary of warrant activity	A summary of warrant activity for the years ended May 31, 2015 and 2014 follows: Number of Warrants Weighted Average Exercise Price Outstanding May 31, 2012 - $ - Granted 850,000 0.42 Exercised - - Cancelled - - Outstanding at May 31, 2015 850,000 0.42 Granted - - Exercised - - Cancelled - - Outstanding at May 31, 2015 850,000 $ 0.42
Warrants outstanding	Warrants outstanding at May 31, 2015 consist of: Date Granted Number Outstanding Exercise price Expiration Date June 1, 2012 100,000 $ 1.00 June 1, 2015 June 12, 2012 150,000 $ 1.00 June 12, 2015 June 26, 2012 100,000 $ 1.00 June 26, 2015 January 1, 2013 500,000 $ 0.01 January 1, 2016 Totals 850,000

Fair Value Measurements and D27

Fair Value Measurements and Derivative Liabiliity (Tables)	12 Months Ended
	May. 31, 2015
Fair Value Measurements And Derivative Liabiliity Tables
Recurring Fair Value Measurements	The following table sets forth, by level, the fair value hierarchy the Company's derivative liabilities, from their convertible promissory notes payable, that were accounted for at fair value as of May 31, 2015 and May 31, 2014. Recurring Fair Value Measurements Level 1 Level 2 Level 3 Total Liabilities: Derivative liability – May 31, 2015 $ - $ - $ 2,564,280 $ 2,564,280 Derivative liability – May 31, 2014 $ - $ - $ 1,748,982 $ 1,748,982

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	May. 31, 2015
Income Taxes Tables
Deferred tax liabilities and assets	Significant components of the Company's deferred tax liabilities and assets as of May 31, 2015 and 2014 are as follows: May 31, 2015 2014 Deferred tax assets 5,668,598 5,068,598 Valuation allowance (5,668,598 ) (5,068,598 ) Total deferred tax assets $ - $ -
Effective tax rate	Reconciliation between the statutory rate and the effective tax rate is as follows for the years ended May 31, 2015 and 2014: Federal statutory tax rate (20.0 )% Permanent differences and valuation allowance (20.0 )% Effective tax rate 0.0 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	May. 31, 2015
Commitments And Contingencies Tables
Future Lease Commitments	On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At May 31, 2015, the future lease commitments on this lease for the years ended May 31, are as follows: 2016 $ 58,880 2017 59,520 2018 7,936 Total $ 126,336

Summary of Significant Accoun30

Summary of Significant Accounting Policies (Details) - shares	12 Months Ended
	May. 31, 2015	May. 31, 2014
Summary Of Significant Accounting Policies Details
Convertible notes payable	23,613,258,824	1,568,946,386
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	850,000
Total common shares equivalent	23,664,118,824	1,619,796,386

Investments (Details)

Investments (Details) - USD ($)	May. 31, 2015	May. 31, 2014
Investments Details
Imagic Ltd. - 40% equity interest	$ 1,094,166	$ 1,094,166
Barefoot Science Products & Services Inc. - 15% equity interest	50,000	50,000
Total	$ 1,144,166	$ 1,144,166

Investments (Details 1)

Investments (Details 1) - USD ($)	May. 31, 2015	May. 31, 2014
Investments Details
July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.	99,200
Cash payments to or for the benefit of Imagic Ltd.	$ 147,466
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings	150,000
Total	$ 1,094,166	$ 1,094,166

Investments (Details 2)

Investments (Details 2)	May. 31, 2015USD ($)
Investments Details 2
January 25, 2013 cancellation of the Marketing and Distribution Agreement dated June 20, 2012	$ 5,000
May 14, 2014 issuance of 15,000,000 shares of DoMark common stock to Lance Todd pursuant to Agreement of Understanding dated March 27, 2014	45,000
Total	$ 50,000

Licensing Agreement With Wazz34

Licensing Agreement With Wazzamba Sa (Details) - USD ($)	May. 31, 2015	May. 31, 2014
Licensing Agreement With Wazzamba Sa Details
Wazzamba, S.A.	$ 300,000	$ 300,000
Bioharmonics	10,000	10,000
Subtotal	310,000	310,000
Accumulated amortization	(268,338)	(60,898)
Total	$ 41,662	$ 249,102

Loans Payable to Consultants an

Loans Payable to Consultants and Stockholders (Details) - USD ($)	May. 31, 2015	May. 31, 2014
Loans payable to consultants and stockholders	$ 189,928	$ 188,972
Consultant And Stockholder [Member]
Loans payable to consultants and stockholders	80,796	90,402
Chief executive officer/Pres. of DoMark International, Inc. [Member]
Loans payable to consultants and stockholders	$ 45,850	47,500
Non Exec. Chairman of Board of DoMark International, Inc. [Member]
Loans payable to consultants and stockholders		11,875
Chairman Of Barefoot Science And Affiliate [Member]
Loans payable to consultants and stockholders	$ 21,500	21,500
Consultant [Member]
Loans payable to consultants and stockholders	16,097	16,097
Consultant One [Member]
Loans payable to consultants and stockholders	17,085	$ 1,598
Consultant Two [Member]
Loans payable to consultants and stockholders	$ 8,600

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)		12 Months Ended
		May. 31, 2015	May. 31, 2014
Principal Amount		$ 639,894
Unamortized Discount		58,938	$ 674,886
Net Note		$ 580,956	$ 67,414
JMJ Financial Inc. [Member]
Date of Note		Dec. 19, 2013
Interest Rate		10.00%
Maturity date		Dec. 19, 2014
Principal Amount	[1]	$ 24,842
Unamortized Discount		0
Net Note		$ 24,842
JSJ Investments, Inc [Member]
Date of Note		Mar. 7, 2014
Interest Rate		12.00%
Maturity date		Oct. 7, 2014
Principal Amount	[2]	$ 12,130
Unamortized Discount		0
Net Note		$ 12,130
Redwood Fund, III [Member]
Date of Note		Mar. 28, 2014
Interest Rate		10.00%
Maturity date		Sep. 28, 2014
Principal Amount	[3]	$ 35,122
Unamortized Discount		0
Net Note		$ 35,122
Redwood Management, LLC [Member]
Date of Note		Mar. 18, 2014
Interest Rate		10.00%
Maturity date		Sep. 28, 2014
Principal Amount	[2]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
WHC Capital, Inc [Member]
Date of Note		Apr. 14, 2014
Interest Rate		12.00%
Maturity date		Oct. 14, 2014
Principal Amount	[1]	$ 38,200
Unamortized Discount		0
Net Note		$ 38,200
Tonaquint Inc [Member]
Date of Note		Apr. 11, 2014
Interest Rate		12.00%
Maturity date		Oct. 11, 2014
Principal Amount	[2]	$ 40,559
Unamortized Discount		0
Net Note		$ 40,559
JSJ Investments, Inc One [Member]
Date of Note		Apr. 24, 2014
Interest Rate		12.00%
Maturity date		Oct. 24, 2014
Principal Amount	[2]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
Iconic Holdings, LLC [Member]
Date of Note		May 12, 2014
Interest Rate		10.00%
Maturity date		Nov. 12, 2014
Principal Amount	[2]	$ 46,645
Unamortized Discount		0
Net Note		$ 46,645
KBM Worldwide, Inc [Member]
Date of Note		May 16, 2014
Interest Rate		8.00%
Maturity date		Nov. 14, 2014
Principal Amount	[1]	$ 9,410
Unamortized Discount		0
Net Note		$ 9,410
Adar Bays, Inc [Member]
Date of Note		Jun. 3, 2014
Interest Rate		8.00%
Maturity date		Dec. 12, 2014
Principal Amount	[2]	$ 48,654
Unamortized Discount		0
Net Note		$ 48,654
JMJ Financial, Inc One [Member]
Date of Note		Jun. 23, 2014
Interest Rate		10.00%
Maturity date		Dec. 23, 2014
Principal Amount	[1]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
LG Capital, Inc [Member]
Date of Note		Jul. 3, 2014
Interest Rate		8.00%
Maturity date		Jan. 3, 2015
Principal Amount	[4]	$ 36,750
Unamortized Discount		0
Net Note		$ 36,750
Redwood Fund, III One [Member]
Date of Note		Jul. 22, 2014
Interest Rate		10.00%
Maturity date		Jan. 22, 2015
Principal Amount	[2]	$ 100,082
Unamortized Discount		0
Net Note		$ 100,082
KBM Worldwide, Inc One [Member]
Date of Note		Aug. 14, 2014
Interest Rate		8.00%
Maturity date		Feb. 14, 2015
Principal Amount	[5]	$ 27,500
Unamortized Discount		0
Net Note		$ 27,500
LG Capital, Inc One [Member]
Date of Note		Oct. 8, 2014
Interest Rate		8.00%
Maturity date		Apr. 8, 2015
Principal Amount	[4]	$ 3,000
Unamortized Discount		0
Net Note		$ 3,000
Tonaquint, Inc One [Member]
Date of Note		Dec. 2, 2014
Interest Rate		12.00%
Maturity date		Jun. 2, 2015
Principal Amount	[5]	$ 10,000
Unamortized Discount		6,849
Net Note		$ 3,151
LG Capital, Inc. Two [Member]
Date of Note		Dec. 5, 2014
Interest Rate		8.00%
Maturity date		Jun. 5, 2015
Principal Amount	[4]	$ 9,500
Unamortized Discount		6,462
Net Note		$ 3,038
LG Capital, Inc. Three [Member]
Date of Note		Jan. 7, 2015
Interest Rate		8.00%
Maturity date		Jul. 7, 2015
Principal Amount	[4]	$ 22,500
Unamortized Discount		20,763
Net Note		$ 1,737
Curran [Member]
Date of Note		Mar. 15, 2015
Interest Rate		10.00%
Maturity date		Mar. 15, 2015
Principal Amount	[5]	$ 25,000
Unamortized Discount		24,864
Net Note		$ 136
[1]	(i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
[2]	(g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
[3]	(f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
[4]	(a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
[5]	(l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - $ / shares	12 Months Ended
	May. 31, 2015	May. 31, 2014
Stockholders Deficit Details
Outstanding Number of Warrants, Beginning Balance	850,000
Granted		850,000
Exercised
Cancelled
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$ 0.42
Granted		$ 0.42
Exercised
Cancelled
Weighted Average Exercise Price, Ending Balance	$ 0.42	$ 0.42

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - $ / shares	12 Months Ended
	May. 31, 2015	May. 31, 2014	May. 31, 2013
Number Of Warrant Outstanding	850,000	850,000
Warrant [Member]
Date Granted	Jun. 1, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1
Expiration Date	Jun. 1, 2015
Warrant One [Member]
Date Granted	Jun. 12, 2012
Number Of Warrant Outstanding	150,000
Exercise price	$ 1
Expiration Date	Jun. 12, 2015
Warrant Two [Member]
Date Granted	Jun. 26, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1
Expiration Date	Jun. 26, 2015
Warrant Three [Member]
Date Granted	Jan. 1, 2013
Number Of Warrant Outstanding	500,000
Exercise price	$ 0.01
Expiration Date	Jan. 1, 2016

Fair Value Measurements and D39

Fair Value Measurements and Derivative Liabiliity (Details)	May. 31, 2015USD ($)
LIABILITIES
Derivative liability - May 31, 2015	$ 2,564,280
Derivative liability - May 31, 2014	$ 1,748,982
Level 1 [Member]
LIABILITIES
Derivative liability - May 31, 2015
Derivative liability - May 31, 2014
Level 2 [Member]
LIABILITIES
Derivative liability - May 31, 2015
Derivative liability - May 31, 2014
Level 3 [Member]
LIABILITIES
Derivative liability - May 31, 2015	$ 2,564,280
Derivative liability - May 31, 2014	$ 1,748,982

Commitments And Contingencies40

Commitments And Contingencies (Details)	May. 31, 2015USD ($)
Commitments And Contingencies Details
2,016	$ 58,880
2,017	59,520
2,018	7,936
Total	$ 126,336

Income Taxes (Details)

Income Taxes (Details) - USD ($)	May. 31, 2015	May. 31, 2014
Income Taxes Details
Deferred tax assets	$ 5,668,598	$ 5,068,598
Valuation allowance	$ (5,668,598)	$ (5,068,598)
Total deferred tax assets

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	May. 31, 2015
Income Taxes Details 1
Federal statutory tax rate	(20.00%)
Permanent differences and valuation allowance	(20.00%)
Effective tax rate	0.00%

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	May. 31, 2015	May. 31, 2014
Income Taxes Details Narrative
Valuation allowance	$ 5,668,598	$ 5,068,598

Commitments and Contingencies44

Commitments and Contingencies (Details Narrative) - USD ($)	May. 31, 2015	May. 31, 2014
Mr. Andrew Ritchie [Member]
Compensate amount	$ 116,512	$ 165,209
Owed amount	47,500	47,500
Mr. R. Brent Strasler [Member]
Compensate amount	26,500	115,850
Owed amount	$ 0	$ 1,185